Saturday 17 October 2026
Export USPH’s income statement to Excel — free account
U.S. Physical Therapy, Inc.
USPH Healthcare Medical Care Facilities
U.S. Physical Therapy, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $781.0 million, up 16.3% from fiscal 2024. In the quarter to June 2026, revenue grew 8.47%, EPS fell 56.9%, free cash flow fell 8.24% and total debt rose 41.8%, each against the same quarter a year earlier. Dividend growth for ten consecutive years, revenue growth for five; insiders bought in the last twelve months.
85.71
0.27
−0.31%
Follow USPH
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 4.34% | 5.30% | 8.19% | 8.84% |
+8 more TTM periods Free account |
|
Piotroski F-Score |
6 | 6 | 7 | 5 | |
| 1.70% | 2.12% | 3.34% | 3.93% | ||
ROIC |
7.48% | 7.83% | 9.12% | 8.95% | |
Return on Tangible Assets |
29.44% | 42.49% | 108.15% | 75.93% | |
Average Days of Receivables |
44.11 | 44.38 | 41.28 | 43.92 | |
Free Cash Flow per Share |
4.25 | 4.40 | 4.02 | 3.74 | |
Free Cash Flow |
64.07 | 66.68 | 60.99 | 56.90 | |
Capital Expenditures |
(18.98) | (16.86) | (14.07) | (12.63) | |
| Other line items | |||||
Cash ROIC |
9.29% | 9.64% | 9.17% | 8.28% | |
Accounts Receivable Turnover |
8.48 | 8.48 | 8.98 | 9.01 | |
Accounts Payable Turnover |
118.83 | 100.28 | 105.26 | 89.51 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
3.82 | 3.83 | 3.50 | 4.39 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.26) | (0.26) | (0.25) | (0.24) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
8.97% | 8.96% | 8.87% | 8.79% | |
Share Based Compensation of Revenue |
1.21% | 1.11% | 1.06% | 1.07% | |
Interest Coverage |
7.11 | 7.97 | 9.16 | 9.78 | |
Operating CF/Net income |
4.02 | 3.25 | 1.90 | 1.59 | |
Depreciation/Fixed assets |
0.56 | 0.59 | 0.64 | 0.70 | |
Capex/Depreciation |
(0.83) | (0.73) | (0.62) | (0.53) | |
Revenue per Share |
53.90 | 52.45 | 51.47 | 49.90 | |
Operating CF per Share |
5.51 | 5.51 | 4.95 | 4.57 | |
Capex per Share |
(1.26) | (1.11) | (0.93) | (0.83) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 |
Columns are period end dates